Extended benefit from sequential administration of docetaxel after standard fluoroura- cil,epirubicin, and cyclophosphamide regimen for node-positive breast cancer:the 8-year follow-up results of the UNICANCER- PACS01 trial

查看全文 作　　者：Coudent B; Asselain B;Campone M; 出　　处：《Oncoloqist》索引2012年第17卷第7期,共0页